.Atea Pharmaceuticals' antiviral has neglected an additional COVID-19 test, yet the biotech still ke...
.Neurocrine Biosciences' mental illness plan pivot has stopped working. The biotech was unable to re...
.Sanofi has actually made a late entry to the radioligand party, paying 100 million euros ($ 110 mil...
.After F2G's initial effort to acquire a brand-new class of antifungal to market was actually derail...
.Moderna has pledged to cut R&D spending through $1.1 billion by 2027. The selection to shrink th...
.Simply four months after Sanofi bet $80 thousand in upfront cash money on Key Therapies' losmapimod...
.Cancer provider Oncternal Therapeutics is folding all its own clinical trials and giving up personn...
.Roche is actually keeping out chances that its injectable obesity possibility might ultimately show...
.Novo Nordisk has elevated the top on a stage 1 trial of its oral amylin as well as GLP-1 receptor c...
.Simply a few short full weeks after winning an FDA Fast lane tag for its investigational BTK degrad...